{"id":"W2565133281","doi":"10.1182/blood.v112.11.2767.2767","title":"Phase II Testing of Lenalidomide Plus Melphalan for Previously Untreated Older Patients with Multiple Myeloma: The NCIC CTG MY.11 Trial","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre; Victoria Hospital; University of Calgary; Queen's University; McMaster University; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Lenalidomide; Neutropenia; Multiple myeloma; Melphalan; Internal medicine; Toxicity; Phases of clinical research; Gastroenterology; Febrile neutropenia; Tolerability; Surgery; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002966351,0.001228053,0.001368208,0.0003275568,0.0004701523,0.001090037,0.001139278,0.001786581,0.004343242],"category_scores_gemma":[0.001640855,0.0003661203,0.0009654785,0.0004862134,0.0006978668,0.0005671575,0.0004648662,0.00413634,0.0007977897],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00167255,"about_ca_system_score_gemma":0.002072099,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001986142,"about_ca_topic_score_gemma":0.006331339,"domain_scores_codex":[0.9991943,0.0005456365,0.00003084015,0.00008139147,0.00006552425,0.00008228471],"domain_scores_gemma":[0.9988249,0.0002038838,0.0002506817,0.00007972808,0.00006498484,0.0005757978],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8561567,0.02308245,0.01175751,0.001195803,0.00198141,0.0004625014,0.0002814126,0.001908484,0.01581688,0.0004249004,0.01639832,0.07053354],"study_design_scores_gemma":[0.7987542,0.1713668,0.01841464,0.0001357493,0.0007180797,0.0003762162,0.00005416043,0.001036736,0.001384577,0.000255673,0.007464335,0.00003886903],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9756283,0.006098528,0.0004076249,0.002923071,0.0003622194,0.004298255,0.003177769,0.0001285105,0.006975782],"genre_scores_gemma":[0.9812018,0.001986644,0.001453719,0.003633855,0.00033546,0.003950287,0.004267683,0.00002942176,0.003141148],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004343242,"threshold_uncertainty_score":0.0156877,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04342470690850933,"score_gpt":0.2986483750118101,"score_spread":0.2552236681033008,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}